Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis

Cardiovascular Pathology

Volumn 17, Issue 2, 2008, Pages 81-92

  Ruppert, Volker ^a   Meyer, Thomas ^a   Pankuweit, Sabine ^a   Jonsdottir, Thuridur ^a   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cardiomyopathy; Coxsackievirus adenovirus receptor; Gene expression; Myocardial inflammation; STAT transcription factor

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; GAMMA INTERFERON; STAT1 PROTEIN; VIRUS RNA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; COXSACKIE VIRUS B3; GENE; GENE EXPRESSION REGULATION; HEART; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INOCULATION; IRF1 GENE; MALE; MIG GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; VIRUS MYOCARDITIS; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENETIC VECTORS; HUMANS; INTERFERON TYPE II; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VIRUS; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 40149095736     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2007.07.004     Document Type: Article

References (43)

1. Coyne C., and Bergelson J. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 57 (2005) 869-882
2. Hauwel M., Furon E., and Gasque P. Molecular and cellular insights into the coxsackie-adenovirus receptor: role in cellular interactions in the stem cell niche. Brain Res Rev 48 (2005) 265-272
3. Raschperger E., Thyberg J., Pettersson S., Philipson L., Fluxe J., and Pettersson R. The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis. Exp Cell Res 312 (2006) 1566-1580
4. Bergelson J., Cunningham J., Droguett G., Kurt-Jones E., Krithivas A., Hong J., Horwitz M., Crowell R., and Finberg R. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275 (1997) 1320-1323
5. Tomko R., Xu R., and Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94 (1997) 3352-3356
6. Honda T., Saitoh H., Masuko M., Katagiri-Abe T., Tominaga K., Kozakai I., Kobayashi K., Kumanishi T., Watanabe Y., Odani S., and Kuwano R. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Mol Brain Res 77 (2000) 19-28
7. Cohen C., Shieh J., Pickles R., Okegawa T., Hsieh J., and Bergelson J. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A 98 (2001) 15191-15196
8. Fechner H., Noutsias M., Tschoepe C., Hinze K., Wang X., Escher F., Pauschinger M., Dekkers D., Vetter R., Paul M., Lamers J., Schultheiss H., and Poller W. Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling. Identification of a cell-to-cell contact-dependent regulatory mechanism. Circulation 107 (2003) 876-882
9. Kashimura T., Kodama M., Hotta Y., Hosoya J., Yoshida K., Ozawa T., Watanabe R., Okura Y., Kato K., Hanawa H., Kuwano R., and Aizawa Y. Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat. Virchows Arch 444 (2004) 283-292
10. Asher D., Cerny A., Weiler S., Horner J., Keeler M., Neptune M., Jones S., Bronson R., DePinho R., and Finberg R. Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis 42 (2005) 77-85
11. Dorner A., Wegmann F., Butz S., Wolburg-Buchholz K., Wolburg H., Mack A., Nasdala I., August B., Westermann J., Rathjen F., and Vestweber D. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J Cell Sci 118 (2005) 3509-3521
12. Chen J., Zhou B., Yu Q., Shin S., Jiao K., Schneider M., Baldwin H., and Bergelson J. Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves. Circ Res 98 (2006) 923-930
13. Ito M., Kodama M., Masuko M., Yamaura M., Fuse K., Uesugi Y., Hirono S., Okura Y., Kato K., Hotta Y., Honda T., Kuwano R., and Aizawa Y. Expression of coxsackievirus and adenovirus receptor in heart of rats with experimental autoimmune myocarditis. Circ Res 86 (2000) 275-280
14. 5 on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy. Implications for cardiotropic viral infections. Circulation 104 (2001) 275-280
15. Darnell J., Kerr I., and Stark G. Jak-STAT pathway and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
16. Darnell J. STATs and gene regulation. Science 277 (1997) 1630-1635
17. Shuai K., Stark G., Kerr I., and Darnell Jr. J. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 261 (1993) 1744-1746
18. Greenlund A., Morales M., Viviano B., Yan H., Krolewski J., and Schreiber R. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 2 (1995) 677-687
19. Shuai K., Horvath C., Huang L., Qureshi S., Cowburn D., and Darnell J. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76 (1994) 821-828
20. Decker T., Kovarik P., and Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 17 (1997) 121-134
21. Meyer T., Marg A., Lemke P., Wiesner B., and Vinkemeier U. DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. Genes Dev 17 (2003) 1992-2005
22. Imanaka-Yoshida K., Hiroe M., Yasutomi M., Toyozaki T., Tsuchiya T., Noda N., Maki T., Nishikawa T., Sakakura T., and Yoshida T. Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol 197 (2002) 388-394
23. Morimoto S., Imanaka-Yoshida K., Hiramitsu S., Kato S., Ohtsuki M., Uemura A., Kato Y., Nishikawa T., Toyozaki T., Hishida H., Yoshida T., and Hiroe M. Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis. J Pathol 205 (2005) 460-467
24. van Houten N., Bouchard P., Moraska A., and Huber S. Selection of an attenuated coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J Virol 65 (1991) 1286-1290
25. Pfaffl M. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
26. Wichmann D., Schwarz R., Ruppert V., Ehrhardt S., Cramer J., Burchard G., Maisch M., and Debierre-Grockiego F. Plasmodium falciparum glycosylphosphatidylinositol induces limited apoptosis in liver and spleen mouse tissue. Apoptosis 12 (2007) 1037-1041
27. Inoue J., Gohda J., Akiyama T., and Semba K. NF-κb activation in development and progression of cancer. Cancer Sci 98 (2007) 268-274
28. Wang L., Tanaka S., and Ramirez F. GATA-4 binds to an upstream element of the human α2(I) collagen gene (COL1A2) and inhibits transcription in fibroblasts. Matrix Biol 24 (2005) 333-340
29. Ehret G., Reichenbach P., Schindler U., Horvath C., Fritz S., Nabholz M., and Bucher P. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 276 (2001) 6675-6688
30. Henry W., Gardin J., and Ware J. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 62 (1980) 1054-1061
31. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., and Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 93 (1996) 841-842
32. Maisch B., Richter A., Sandmöller A., Portig A., Pankuweit S., and for the BMBF-Heart Failure Network. Inflammatory dilated cardiomyopathy. Herz 30 (2005) 535-544
33. Pankuweit S., Moll R., Baandrup U., Portig I., Hufnagel G., and Maisch B. Prevalence of the Parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34 (2003) 497-503
34. Bowles N., Richardson P., Olsen E., and Archard L. Detection of coxsackie-B-virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1 (1986) 1120-1123
35. Herzum M., Ruppert V., Kuytz B., Jomaa H., Nakamura I., and Maisch B. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol 26 (1994) 907-913
36. Sasse A., Wallich M., Ding Z., Goedecke A., and Schrader J. Coxsackie-and-adenovirus receptor mRNA expression in human heart failure. J Gene Med 5 (2003) 876-882
37. Ahn J., Joo C., Seo I., Kim D., Kim Y., and Lee H. All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J Med Virol 75 (2005) 290-294
38. Bowles N., Javier Fuentes-Garcia F., Makar K., Li H., Gibson J., Soto F., Schwimmbeck P., Schultheiss H., and Pauschinger M. Analysis of the coxsackievirus B-adenovirus receptor gene in patients with myocarditis or dilated cardiomyopathy. Mol Genet Metab 77 (2002) 257-259
39. Fuse K., Chan G., Liu Y., Gudgeon P., Husain M., Chen M., Yeh W., Akira S., and Liu P. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112 (2005) 2276-2285
40. Yasukawa H., Yajima T., Duplain H., Iwatate M., Kido M., Hoshijima M., Weitzman M., Nakamura T., Woodard S., Xiong D., Yoshimura A., Chien K., and Knowlton K. The suppressor of cytokine signalling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest 111 (2003) 469-478
41. Zen K., Liu Y., McCall I., Wu T., Lee W., Babbin B., Nusrat A., and Parkos C. Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. Mol Biol Cell 16 (2005) 2694-2703
42. Kim M., Sumerel L., Belousova N., Lyons G., Carey D., Krasnykh V., and Douglas J. The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br J Cancer 88 (2003) 1411-1416
43. Okegawa T., Pong R., Li Y., Bergelson J., Sagalowsky A., and Hsieh J. The mechanism of the growth-inhibitory effect of coxsackievirus and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of CAR protein structure. Cancer Res 61 (2001) 6592-6600